MedPath

Application and Evaluation of Transference Focused Psychotherapy Modified for Adolescents

Not Applicable
Conditions
Behavior Problems
Identity Pathology
Registration Number
NCT00571571
Lead Sponsor
Weill Medical College of Cornell University
Brief Summary

Normal adolescence requires a successful resolution of identity crisis, which results in the development of satisfying relationships, success in school/work pursuits, and achievement of personal goals. Adolescents, who do not resolve this crisis, are at high risk for problems in those areas of functioning. Transference Focused Psychotherapy for Adolescents (TFP-A) is a treatment that specifically addresses these issues, permitting adolescents to develop satisfying friendships, more appropriate interactions with authority, and achieve realistic life goals.

This study will evaluate the application of TFP-A, (a empirically validated treatment for adults with identity disturbance), to adolescents exhibiting the same behavioral and identity pathology. Subjects will be females; ages 14-21, with behaviors associated with identity problems, interpersonal difficulties with teachers, parents and/or peers, and live with their families. These adolescents will be randomly assigned to one of two treatment cells, TFP-A or Treatment as Usual (TAU). Subjects in TFP-A will receive weekly individual therapy for six months. The TAU group will receive standard individual therapy in the Outpatient Department. Both will receive medication as necessary. All subjects will participate in initial, weekly, and bi-monthly assessments during the six-month treatment period, and participate in a naturalistic follow-up study for an additional six months.

Hypothesis:

Adolescents with identity problems as seen in interpersonal, school, and/or family difficulties in the Transference Focused Psychotherapy for Adolescents (TFP-A) group will reduce these problem behaviors and improve management of their feelings and moods compared to adolescents with identity problems in the treatment as usual control group (TAU).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
20
Inclusion Criteria
  1. Female Adolescents, ages 14-21
  2. A score of five out of nine critical items on the Borderline Personality Disorder Dimension Interview Scale.
  3. Have interpersonal difficulties in school, family, and/or peer functioning.
  4. Live at home with family.
  5. Willingness to attend evaluation sessions and weekly, individual therapy.
Exclusion Criteria
  1. The presence of psychosis, substance dependence, non-verbal learning disability, antisocial behavior, and/or primary diagnoses of eating disorder, bipolar disorder, and obsessive-compulsive disorder.
  2. The need for hospitalization for symptom management.
  3. Significant cognitive impairment (Full Scale IQ <85).
  4. The presence of a life-threatening medical illness.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Reduction in interpersonal difficulties with parents, teachers, and/or peers. Improved management of their feelings and moods. Reduction in other problems behaviors (i.e. substance use, self-injurious behaviors)Subjects will be assessed at entry, 2 month, 4 months, 6 months, 8 months 10 months, and 12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

New York-Presbyterian Hospital

🇺🇸

White Plains, New York, United States

New York-Presbyterian Hospital
🇺🇸White Plains, New York, United States
Maura L Lehr, LCSW
Contact
914-997-5866
mll9001@nyp.org
Anna E Odom, Ph.D.
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.